Dr Kelvin Stott

Director of Portfolio Management, Novartis

Kelvin is currently Director of Portfolio Management at Novartis in Basel, Switzerland, where he is responsible for evaluating project and portfolio investment decisions to support the company’s global drug development pipeline.  He is a globally recognized and respected thought leader in biopharma innovation and R&D productivity, with over 20 years of experience in various roles across big pharma (Novartis, Merck Serono), biotech start-ups (Senexis), management consulting (McKinsey, PwC, Quantelium) and venture capital (Inventages).  A firm believer in the importance and need for unconventional critical strategic thinking to challenge and disrupt the status quo, he lives by the entrepreneurial spirit and motto to “aim high, think big and different, start small, fail cheap and learn fast”.  Kelvin holds a PhD in protein engineering from Trinity College at the University of Cambridge, and was also a Research Fellow at Peterhouse.